| Hang Seng Index | 25.060 HKD | -0.200 | -0.792% | 497.41M | 12.54B | 25.271 (-0.835%) HKD as at 2025/07/31 | | |
| Hang Seng TECH Index | 5.325 HKD | -0.030 | -0.560% | 1.71B | 9.14B | 5.396 (-1.310%) HKD as at 2025/07/30 | | |
| Hang Seng China Enterprises | 90.340 HKD | -0.600 | -0.660% | 50.90M | 4.62B | 90.933 (-0.652%) HKD as at 2025/07/31 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.285 HKD | -0.070 | -1.307% | 160.15M | 855.42M | 5.446 (-2.956%) HKD as at 2025/07/30 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.630 HKD | +0.022 | +1.368% | 290.98M | 470.17M | 1.587 (+2.729%) HKD as at 2025/07/30 | | |
| Hang Seng China Enterprises | 10.470 HKD | -0.060 | -0.570% | 32.09M | 336.98M | 10.745 (-2.558%) HKD as at 2025/07/30 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 2.106 HKD | +0.040 | +1.936% | 152.18M | 317.31M | 2.003 (+5.127%) HKD as at 2025/07/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.480 HKD | -0.100 | -1.792% | 43.14M | 239.30M | 5.775 (-5.113%) HKD as at 2025/07/30 | | |
| Hang Seng TECH Index | 11.430 HKD | -0.060 | -0.522% | 19.50M | 223.76M | 11.572 (-1.226%) HKD as at 2025/07/30 | | |
| Hang Seng TECH Index | 5.410 HKD | -0.030 | -0.551% | 19.86M | 107.96M | 5.479 (-1.252%) HKD as at 2025/07/30 | | |
| MSCI Asia APEX 50 | 63.380 HKD | -1.240 | -1.919% | 1.53M | 97.27M | 64.951 (-2.418%) HKD as at 2025/07/30 | | |
| FTSE China A50 | 14.520 HKD | -0.180 | -1.224% | 4.43M | 64.44M | 14.917 (-2.659%) HKD as at 2025/07/30 | | |
| CSI 300 | 45.500 HKD | -0.480 | -1.044% | 1.37M | 62.61M | 46.932 (-3.051%) HKD as at 2025/07/30 | | |
| HSI ESG Enhanced Index (net total return index) | 51.960 HKD | -0.400 | -0.764% | 720.01K | 37.46M | 52.382 (-0.806%) HKD as at 2025/07/31 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 16.240 HKD | -0.420 | -2.521% | 1.96M | 32.43M | 16.727 (-2.913%) HKD as at 2025/07/31 | | |
| FTSE China A50 | 13.550 HKD | -0.120 | -0.878% | 1.95M | 26.50M | 13.945 (-2.830%) HKD as at 2025/07/30 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.908 HKD | +0.196 | +5.280% | 6.05M | 23.46M | 3.821 (+2.288%) HKD as at 2025/07/30 | | |
| London Gold Fixing Price | 2,380.000 HKD | -10.000 | -0.418% | 8.50K | 20.23M | N/A | | |
| FTSE US Treasury 20+ Years Index | 67.660 HKD | -0.460 | -0.675% | 287.79K | 19.51M | 67.846 (-0.273%) HKD as at 2025/07/30 | | |
| MSCI India Net Total Return (USD) Index | 6.885 HKD | -0.055 | -0.793% | 2.52M | 17.38M | 6.987 (-1.453%) HKD as at 2025/07/30 | | |
| Hang Seng High Dividend Yield | 29.420 HKD | -0.240 | -0.809% | 560.92K | 16.57M | 30.185 (-2.535%) HKD as at 2025/07/30 | | |
| CSI China Reform Hong Kong Connect Central-SOEs High Dividend Yield Index | 9.880 HKD | -0.150 | -1.496% | 1.60M | 15.87M | 9.908 (-0.280%) HKD as at 2025/07/31 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 14.210 HKD | -0.480 | -3.268% | 815.00K | 11.61M | 14.682 (-3.213%) HKD as at 2025/07/31 | | |
| CME CF Ether-Dollar Reference Rate - Asia Pacific Variant | 8.750 HKD | -0.545 | -5.863% | 1.12M | 9.94M | 9.282 (-5.728%) HKD as at 2025/07/31 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 3.822 HKD | -0.058 | -1.495% | 2.33M | 8.93M | 3.914 (-2.338%) HKD as at 2025/07/31 | | |
| CME Ether Futures | 17.220 HKD | -1.080 | -5.902% | 504.40K | 8.77M | 17.821 (-3.372%) HKD as at 2025/07/30 | | |
| CSI Hong Kong Dividend | 36.740 HKD | -0.520 | -1.396% | 236.80K | 8.73M | 37.292 (-1.479%) HKD as at 2025/07/31 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises | 3.366 HKD | -0.094 | -2.717% | 2.54M | 8.66M | 3.533 (-4.724%) HKD as at 2025/07/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index (HKD)(CNH) | 4.306 HKD | -0.054 | -1.239% | 1.67M | 7.24M | 4.558 (-5.518%) HKD as at 2025/07/30 | | |
| Hang Seng TECH Index | 6.895 HKD | -0.060 | -0.863% | 1.03M | 7.15M | 6.949 (-0.780%) HKD as at 2025/07/31 | | |